Key terms

About ELV

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ELV news

Apr 22 4:05am ET Elevance Health Outperforms with Strong MLR and EPS Growth Potential: A Buy Rating Justified Apr 22 2:46am ET Elevance Health: Strong Q1 Performance and Strategic Initiatives Underpin Buy Rating Apr 22 1:15am ET Elevance Health: A Strong Buy on Sustained Margin Growth and Operational Excellence Apr 19 9:33am ET Elevance Health price target raised to $600 from $580 at Truist Apr 19 8:52am ET Elevance Health price target raised to $575 from $574 at RBC Capital Apr 19 8:20am ET Elevance Health price target raised to $600 from $557 at Wells Fargo Apr 19 7:20am ET Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Elevance Health (ELV) Apr 19 7:12am ET Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Sarepta Therapeutics (SRPT) and Intuitive Surgical (ISRG) Apr 19 7:03am ET Elevance Health price target raised to $605 from $585 at UBS Apr 19 5:50am ET Analysts’ Top Healthcare Picks: Elevance Health (ELV), Argenx Se (ARGX) Apr 19 5:18am ET Elevance Health price target raised to $621 from $584 at Barclays Apr 19 4:11am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Adaptimmune Therapeutics (ADAP) Apr 18 9:30pm ET Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Elevance Health (ELV) Apr 18 1:13pm ET Elevance Health price target raised to $600 from $580 at Cantor Fitzgerald Apr 18 10:29am ET Hospital survey weakened ‘dramatically’ in March, says TD Cowen Apr 18 9:56am ET Early notable gainers among liquid option names on April 18th Apr 18 7:05am ET Options Volatility and Implied Earnings Moves Today, April 18, 2024 Apr 18 6:03am ET Elevance Health reports Medical membership totaled ~46.2M at March 31 Apr 18 6:01am ET Elevance Health raises FY24 adjusted EPS view to greater than $37.20 per share Apr 18 6:00am ET Elevance Health reports Q1 adjusted EPS $10.64, consensus $10.53 Apr 17 8:25pm ET Notable companies reporting before tomorrow’s open Apr 17 1:19pm ET Notable companies reporting before tomorrow’s open Apr 17 5:10am ET Buy Rating for Elevance Health: Carelon’s Growth Trajectory and Expansion Potential Drive Long-Term Value Apr 17 5:10am ET Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Ocular Therapeutix (OCUL) and Elevance Health (ELV) Apr 15 10:37am ET Centene rises, Molina slides following Florida’s managed Medicaid awards Apr 15 7:37am ET Elevance Health,CD&R in primary care delivery pact, terms undisclosed Apr 15 7:00am ET Options Volatility and Implied Earnings Moves This Week, April 15 – April 19, 2024 Apr 15 6:16am ET Molina Healthcare price target lowered to $410 from $440 at Wells Fargo Apr 15 6:15am ET Centene price target raised to $93 from $89 at Wells Fargo Apr 15 6:06am ET Elevance Health (ELV) Receives a Buy from Wells Fargo Apr 15 4:26am ET Barclays Keeps Their Buy Rating on Elevance Health (ELV)

No recent press releases are available for ELV

ELV Financials

1-year income & revenue

Key terms

ELV Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ELV Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms